Disease-Modifying Immunotherapy
The first type of treatment is disease-modifying immunotherapy,
which uses one of several approved
drug therapies to slow MS activity
and progression. The most commonly prescribed medications are the “ABCR” drugs
(Avonex®, Betaseron®, Copaxone®, and Rebif®). These
are given via self-injection at home, varying from one to seven
times per week. Other drugs, such as Novantrone®, are given
periodically via intravenous injection
(IV) by a medical professional.
The majority of individuals with MS may benefit from taking one
of these immunotherapy drugs. Research has shown that early treatment
is the most effective strategy in minimizing damage to the nerves.
Newly diagnosed individuals, as well as individuals diagnosed previously
who are not on an immunotherapy, should speak with their physician
to see if they may benefit from this type of treatment.
|
Drugs for Managing MS
and Its Symptoms
(As listed by MSAA Chief Medical Officer Jack Burks, MD)
Betaseron® (interferon beta-1b)
Patient support at MS Pathways, 1-800-788-1467
or www.mspathways.com; www.multiplesclerosis.com
Avonex® (interferon beta-1a)
Patient support at Avonex Alliance, 1-800-456-2255
or www.avonex.com
Copaxone® (glatiramer acetate)
Patient support at Shared Solutions, 1-800-887-8100
or www.sharedsolutions.com
Rebif® (interferon beta-1a)
Patient support at MS LifeLines, 1-877-447-3243
or www.MSLifeLines.com
Novantrone® (mitoxantrone)
Patient support at MS LifeLines, 1-877-447-3243
or www.novantrone.com
Methotrexate
Imuran® (azathioprine)
Cytoxan® (cyclophosphamide)
Pulse Solu-Medrol® (IV methylprednisolone)
|
